These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 12756647)

  • 1. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
    Henze M; Mohammed A; Schlemmer HP; Herfarth KK; Hoffner S; Haufe S; Mier W; Eisenhut M; Debus J; Haberkorn U
    J Nucl Med; 2004 Apr; 45(4):579-86. PubMed ID: 15073253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.
    Choi JY; Kim SE; Shin HJ; Kim BT; Kim JH
    J Neurooncol; 2000; 46(1):63-70. PubMed ID: 10896206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
    Fan YX; Luo RC; Li GP; Zheng H; Huang K
    Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Diagnostic Efficacy of
    Kumar P; Kumar A; Nagaraj C; Sadashiva N; Saini J; Mangalore S; Rajan A; Sitani K; Beniwal M; Santosh V; Basavaraja H; Hazari PP; Mishra AK
    Cancer Biother Radiopharm; 2024 Jun; 39(5):349-357. PubMed ID: 38324045
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in evaluation of primary brain tumors.
    Chen W; Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
    Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
    J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.